Skip to main content
    P

    Phibro Animal Health Corporation (PAHC)

    Official site

    HEALTHCARE • DRUG MANUFACTURERS - SPECIALTY & GENERIC • NASDAQ

    $32.96
    -2.44 (-6.89%)

    Market Cap: $1.44B

    Last updated: Nov 06, 2026 at 4:39 PM ET

    Earnings

    Performance (10Y)

    Beat Rate
    65%(26/40)
    Avg Surprise
    +4.99%
    Streak
    12 Q

    Upcoming Estimates

    Period ending Dec 31, 2026
    EPS Consensus$0.94
    Range$0.91 - $0.97
    2 analysts
    EPS Revisions
    1
    0
    7d
    1
    0
    30d
    EPS Estimate DriftChange to current
    90d ago$0.91+3.3%
    60d ago$0.91+3.3%
    30d ago$0.97-2.7%
    7d ago$0.99-5.1%
    Current$0.94
    Revenue Consensus
    $393M
    Range$393M - $393M
    1 analysts
    Last 12 of 40 reported quarters and 1 upcoming estimate
    PeriodReportedEst.RangeSurpriseB/MAnalystsRevisionsYoY
    Dec 26EST
    		-$0.94$0.91 - $0.97--2
    1
    0
    30d
    		-
    Sep 26
    Reported Nov 4
    		$0.79$0.79$0.76 - $0.81+0.00%Beat3
    0
    1
    30d
    		+8.2%
    Jun 26
    Reported Aug 26
    		$0.85$0.72$0.68 - $0.75+18.06%Beat4
    0
    1
    30d
    		+49.1%
    Mar 26
    Reported May 6
    		$0.76$0.71$0.70 - $0.73+7.04%Beat5
    2
    0
    30d
    		+20.6%
    Dec 25
    Reported Feb 4
    		$0.87$0.67$0.62 - $0.72+29.85%Beat4
    1
    1
    30d
    		+61.1%
    Sep 25
    Reported Nov 5
    		$0.73$0.59$0.52 - $0.68+23.73%Beat3
    1
    0
    30d
    		+108.6%
    Jun 25
    Reported Aug 27
    		$0.57$0.52$0.50 - $0.54+9.62%Beat3
    0
    3
    30d
    		+39.0%
    Mar 25
    Reported May 7
    		$0.63$0.52$0.49 - $0.56+21.15%Beat3
    0
    2
    30d
    		+103.2%
    Dec 24
    Reported Feb 5
    		$0.54$0.45$0.40 - $0.48+20.00%Beat3
    1
    1
    30d
    		+63.6%
    Sep 24
    Reported Nov 7
    		$0.35$0.25$0.20 - $0.30+40.00%Beat4
    1
    0
    30d
    		+150.0%
    Jun 24
    Reported Aug 28
    		$0.41$0.33$0.33 - $0.34+24.24%Beat3
    No revisions (30d)
    		+7.9%
    Mar 24
    Reported May 8
    		$0.31$0.29$0.29 - $0.29+6.90%Beat3
    No revisions (30d)
    		+6.9%
    Dec 23
    Reported Feb 7
    		$0.33$0.28$0.24 - $0.32+17.86%Beat4
    No revisions (30d)
    		-2.9%

    Dividends

    Next ex-dividend: Nov 25, 2026

    Dividend Metrics

    Forward Yield1.46%
    Forward Annual Dividend$0.48
    Payout Ratio18.97%
    FrequencyQuarterly
    Pay MonthsMar, Jun, Sep, Dec

    Growth

    3Y CAGR+0.00%
    5Y CAGR+0.00%
    PAHC dividend history and ex-dividend datesRun PAHC in the free DRIP calculator

    Key Metrics

    Valuation
    P/E Ratio10.08EV/EBITDA8.39x
    Price/FCF61.74xFCF Yield1.62%
    Profitability
    Profit Margin6.57%Operating Margin10.60%
    ROE29.70%ROIC11.69%
    Financial Health
    Debt/Equity1.76xInterest CoverageN/A
    Current Ratio3.20xQuick Ratio1.28x
    Trading Statistics
    Beta0.40Avg Volume216.47K
    52-Week High$59.6452-Week Low$28.04

    Technical Indicators Dashboard

    Moving Averages

    SMA 10$37.72
    SMA 20$38.11
    SMA 50$37.07
    SMA 200$41.00
    EMA 10$37.12
    EMA 20$37.52
    EMA 50$37.08
    EMA 200$37.80

    MACD

    Line: -0.17Signal: 0.41Hist: -0.59

    ADX

    ADX: 22.4+DI: 17.8-DI: 32.0

    Aroon & PSAR

    Aroon Up56.0
    Aroon Down100.0
    PSAR$40.20

    Bollinger Bands

    Upper Band$41.28
    Lower Band$34.94
    %B Position1663%(Upper)
    Band Width-0.31

    RSI (14-Day)

    Neutral
    33.1

    Momentum Oscillators

    Stoch %K22.6
    Stoch %D29.9
    Williams %R-99.4
    ROC (10d)-15.1%
    Momentum-5.84
    CCI (20d)-328.6
    MFI (14d)43.6

    Volatility Measures

    ATR (14d)$1.78(5.4%)
    StdDev (20d)1.58
    Hist Vol54.0%(High)

    Volume Flow

    VWAP$33.85
    OBV259.9K
    AD Line-40.3M
    CMF (20d)-0.309

    Volume Metrics

    Avg Vol (20d)214.4K
    Vol Ratio1.3x
    VWMA (20d)$37.81

    Pivot Points

    R3$42.70
    R2$41.08
    R1$38.24
    Pivot Point$36.62
    S1$33.78
    S2$32.16
    S3$29.32

    Advanced Oscillators

    TSI-2.92
    Ultimate Osc30.0
    KST38.41

    Financial Data

    QuarterSep 2026Jun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024Mar 2024Dec 2023
    Total Revenue$386.77M$396.75M$383.54M$373.91M$363.89M$378.70M$347.82M$309.26M$260.43M$273.16M$263.22M$249.94M
    Cost of Revenue$258.24M$262.35M$257.87M$241.25M$244.11M$268.69M$243.26M$207.39M$176.94M$186.01M$183.62M$171.33M
    Gross Profit$128.54M$134.40M$125.67M$132.66M$119.78M$110.01M$104.57M$101.87M$83.50M$87.15M$79.60M$78.62M
    Operating Expenses$78.90M$86.24M$81.02M$82.33M$68.52M$76.29M$71.05M$76.34M$65.80M$68.73M$59.68M$62.91M
    R&D$0$0$0$0$0$0$0$0$0$0$0$0
    SG&A$78.90M$86.24M$81.02M$82.33M$68.52M$76.29M$71.05M$76.34M$65.80M$68.73M$59.68M$62.91M
    Operating Income$49.64M$48.16M$44.65M$50.33M$51.26M$33.72M$33.52M$25.53M$17.70M$18.42M$19.92M$15.70M
    Interest Income$-11,291,000$-10,183,000$-10,431,000$-11,756,000$-12,059,000$-8,610,000$-9,355,000$-8,996,000$-7,641,000$-4,738,000$-4,575,000$-4,659,000
    Interest Expense$10.86M$15.82M$12.34M$13.90M$14.99M$9.87M$3.83M$20.70M$8.08M$12.01M$7.00M$12.14M
    Income Before Tax$38.78M$32.34M$32.31M$36.42M$36.27M$23.85M$29.69M$4.84M$9.62M$6.41M$12.92M$3.56M
    Income Tax Expense$9.26M$10.63M$8.29M$8.97M$9.74M$6.62M$8.81M$1.65M$2.65M$5.66M$4.52M$2.29M
    Net Income$29.52M$21.71M$24.02M$27.46M$26.53M$17.22M$20.88M$3.19M$6.97M$752,000$8.40M$1.27M
    EBITDA$64.26M$56.47M$55.76M$61.64M$61.73M$45.44M$52.23M$25.91M$26.63M$20.61M$26.95M$17.39M
    EBIT$50.07M$42.52M$42.74M$48.18M$48.33M$32.46M$39.04M$13.83M$17.26M$11.15M$17.50M$8.22M
    * Some calculated fields are derived from available data when not provided by source

    Related GNG Research

    No research available

    Be the first to write about PAHC

    News

    Phibro Animal Health Reports Q1 FY2027 Net Sales Increase to $386.8 Million

    Phibro Animal Health Corporation reported its first-quarter financial results for FY2027, ending September 30, 2026, with net sales increasing to $386.8 million...

    Kalkine Media•11/4/26•Bullish

    Phibro Animal Health Declares $0.12 Quarterly Dividend

    Phibro Animal Health (PAHC) has declared a quarterly cash dividend of $0.12 per share for both its Class A and Class B common stock. The payment is scheduled for December 16, 2026...

    TradingView•11/4/26•Bullish

    Shareholders will get 12 cents per share from Phibro Animal Health on Dec. 16

    Phibro Animal Health Corporation (Nasdaq: PAHC) has declared a quarterly cash dividend of $0.12 per share for both its Class A and Class B common stock. This dividend is payable on December 16, 2026...

    Stock Titan•11/3/26•Neutral

    Form DEF 14A Phibro Animal Health Corporation For: 2 November By Investing.com

    This article from Investing.com announces that Phibro Animal Health Corporation (PAHC) filed its Form DEF 14A for November 2. The filing is related to the company's stock market activities.

    Investing.com India•11/2/26•Neutral

    Form DEF 14A Phibro Animal Health Corporation For: 2 November By Investing.com

    This article announces that Phibro Animal Health Corporation (PAHC) filed a DEF 14A form for November 2nd. The filing is available through Investing.com...

    Investing.com Canada•11/2/26•Neutral

    PAHC Valuation and Fair Value

    P/E
    10.1x
    Forward P/E
    13.8x
    EV/EBITDA
    8.4x
    P/FCF
    61.7x
    PEG
    1.7x
    P/B
    3.2x
    See GNG's fair value

    PAHC Profitability: Margins, ROIC and FCF

    Gross margin
    33.8%
    Operating margin
    10.6%
    Net margin
    6.6%
    ROIC
    11.7%
    ROE
    29.7%
    FCF margin
    1.4%
    FCF yield
    1.6%

    PAHC Competitors

    CompanyTicker
    U.S. Physical Therapy, Inc.USPH
    UroGen Pharma LtdURGN
    Pacira BioSciences, Inc.PCRX
    Enovis CorpENOV
    Immunocore Holdings LtdIMCR
    Rapport Therapeutics, Inc. Common StockRAPP
    Nuvation Bio IncNUVB
    Nutex Health IncNUTX

    Sector: Healthcare

    PAHC Analyst Ratings

    Consensus
    Hold
    Analysts
    4
    Strong Buy
    1
    Buy
    0
    Hold
    2
    Sell
    0
    Strong Sell
    1

    PAHC Bull Case vs Bear Case

    Bull case

    • PAHC beat EPS estimates in 87.5% of its last 8 reported quarters.

    PAHC Earnings: Beat Rate and Next Report

    Beat rate
    7 of 8 quarters (87.5%)
    Average surprise
    16.2%
    EPS estimate (fiscal period ending Dec 31, 2026)
    $0.94
    Estimate revisions (30 days, fiscal period ending Dec 31, 2026)
    1 up, 0 down

    PAHC Dividend

    Forward yield
    1.5%
    Payout ratio
    19.0%
    3Y DPS growth
    0.0%
    5Y DPS growth
    0.0%
    Pay months
    Mar, Jun, Sep, Dec
    PAHC dividend history

    PAHC Earnings Date

    PAHC reports Feb 2, 2027. The date is estimated.

    PAHC Earnings Call

    The latest PAHC earnings call transcript on file is labeled 2026Q3.

    Read the 2026Q3 transcript

    PAHC ETF Holders

    GNG tracks 9 ETFs that hold PAHC. The largest weights:

    1. State Street SPDR S&P Pharmaceuticals ETF (XPH), 1.25% of the fund
    2. Fidelity Enhanced Small Cap Core ETF (FESM), 0.05% of the fund
    3. iShares Core S&P Small-Cap ETF (IJR), 0.05% of the fund
    4. iShares Russell 2000 ETF (IWM), 0.03% of the fund
    5. Vanguard Russell 2000 Index Fund ETF Shares (VTWO), 0.03% of the fund
    Open the ETF Stock Exposure tool for PAHC

    See insider activity

    Frequently Asked Questions About PAHC

    When is PAHC's next ex-dividend date?

    PAHC's next ex-dividend date is Nov 25, 2026, for a declared dividend of $0.12 per share (record date Nov 25, 2026, payable Dec 16, 2026).

    When does PAHC report earnings?

    Phibro Animal Health Corporation (PAHC) is expected to report earnings on Feb 2, 2027.

    What is PAHC's current dividend yield?

    Phibro Animal Health Corporation (PAHC) has a forward dividend yield of 1.46%.

    Does PAHC pay dividends?

    Yes, Phibro Animal Health Corporation pays dividends with a forward dividend yield of 1.46%.

    What is PAHC's P/E ratio?

    Phibro Animal Health Corporation has a price-to-earnings (P/E) ratio of 10.08.

    Related stocks

    Sector: Healthcare

    All stocks starting with P

    Get full access to GNG Research

    Create a free account to access portfolio tracking, advanced tools, and more.

    Create Free AccountLog In